Hospital Israelita Albert Einstein Selects Cerner Millennium® Solutions to Streamline Operations
15 October 2013
KANSAS CITY, Mo., U.S.A. and SAO PAULO — Sept. 23, 2013 — Hospital Israelita Albert Einstein, a private, 647-bed hospital with eight ambulatory clinics in São Paulo, will be the first in Brazil to implement Cerner Millennium® health care information technology (HIT) solutions. The technology will help streamline operations in multiple areas of the hospital, while improving care for all patients.
Considered the best hospital in Latin America, Hospital Israelita Albert Einstein was the first outside of the United States to receive international accreditation from the Joint Commission International.
“Albert Einstein hospital is extremely progressive in terms of quality and technology, and we look for the same characteristics in our suppliers and partners”,,” said Dr. Claudio Lottenberg, President of Hospital Israelita Albert Einstein. “Our clinical activity is centered on the patient. By introducing Cerner’s integrated technology, we will be able to deliver efficient care and increase patient safety.
With the implementation at Hospital Israelita Albert Einstein, Cerner will have clients in 24 countries. Albert Einstein will be the first client to leverage Cerner Millennium in Portuguese.
“We are excited to announce our entry into the Brazilian health IT market with this preeminent hospital,” said Neal Patterson, Cerner Chief Operating Office. “For more than three decades, Cerner has been addressing important challenges in health care with technology, knowledge and content, working with clients in 24 countries to improve efficiency, reduce costs and elevate the standard of care. It will be rewarding to partner with Hospital Israelita Albert Einstein to deploy all of our solutions for improving the health of populations. Together with Einstein, we share a mission of advancing excellence in health care and enhancing the quality of life for people and communities.”
The first phase of the project will include: translation of Millennium into Portuguese, Orders, Documentation, electronic medical record (EMR), Pharmacy, Patient Management, Billing, ER, ICU, Oncology, Cardiology, Laboratory, Surgery, Ambulatory process, Medication Administration, Women’s Health and various Lighthouse solutions among others across the main acute care facility and clinics. This project demonstrates the flexibility of the Cerner Millennium architecture to meet the language and workflow requirements of those in different countries around the world.
Cerner is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. We started with the foundation of digitizing paper processes and now offer the most comprehensive array of information software, professional services, medical device integration, remote hosting and employer health and wellness services. Cerner systems are used by everyone from individual consumers, to single-doctor practices, hospitals, employers and entire countries. Taking what we’ve learned over more than three decades, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care.
Cerner® solutions are licensed by approximately 10,000 facilities around the world, including more than 2,700 hospitals; 4,150 physician practices; 45,000 physicians; 550 ambulatory facilities, such as laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 45 employer sites and 1,750 retail pharmacies.
Certain trademarks, service marks and logos (collectively, the “Marks”) set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. All other non-Cerner Marks are the property of their respective owners. Nasdaq: CERN. For more information about Cerner, please visit www.cerner.com, Twitter, Facebook and YouTube.
Cerner Media Contact: Megan Moriarty, (816) 888-2470, email@example.com
Cerner Investors Contact: Allan Kells, (816) 201-2445, firstname.lastname@example.org
About Sociedade Beneficente Israelita Brasileira Albert Einstein (SBIBAE)
The SBIBAE operates in three integrated and equally important fronts: health care, social responsibility and the generation and dissemination of knowledge. The activities of health care are concentrated in the Hospital Israelita Albert Einstein and in the area of preventive and diagnostic medicine, that contribute to the sustainability of social responsibility, teaching and research. The Instituto Israelita Albert Einstein de Responsabilidade Social (IIRS) works in its ows programs or in conjunction with public health system to help meet the health care needs, or technological skills of the community. The research and education activities are housed in the Instituto Israelita de Ensino e Pesquisa (IIEP) and confer innovation to other areas of SBIBAE.
Hospital Israelita Albert Einstein Media Contact: Mirtes Bogéa (55.02111.2151-0349) mirtes.bogea @einstein.br
Camila Abranches (55-02111-2151-0464) email@example.com
This release contains forward-looking statements that involve a number of risks and uncertainties. It is important to note that the Company's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words “XXX” or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: [the possibility of product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our data centers or client support facilities; our proprietary technology may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others; risks associated with our non-U.S. operations; risks associated with our ability to effectively hedge exposure to fluctuations in foreign currency exchange rates; the potential for tax legislation initiatives that could adversely affect our tax position and/or challenges to our tax positions in the United States and non-U.S. countries; risks associated with our recruitment and retention of key personnel; risks related to our dependence on third party suppliers; risks inherent with business acquisitions; the potential for losses resulting from asset impairment charges; risks associated with uncertainty in global economic conditions; managing growth in the new markets in which we offer solutions, health care devices and services; changing political, economic, regulatory and judicial influences; government regulation; significant competition and market changes; variations in our quarterly operating results; potential inconsistencies in our sales forecasts compared to actual sales; the volatility in the trading price of our common stock and the timing and volume of market activity; our directors’ authority to issue preferred stock and the anti-takeover provisions in our corporate governance documents; material adverse resolution of legal proceedings; [and, failure of the parties to achieve the intended benefits][failure to reach the intended synergies. Additional discussion of these and other risks, uncertainties and factors affecting the Company's business is contained in the Company's periodic filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. The Company undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.